In mice, Adcy3 deficiency leads to impaired insulin sensitivity and dyslipidemia [43], and studies in humans have found that loss-of-function variants in ADCY3 increase the risk for obesity and type 2 diabetes [44]. This evidence concerns the gene INS and metabolic syndrome.